» Articles » PMID: 20679558

Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: the CARDIA (Coronary Artery Risk Development in Young Adults) Study

Overview
Journal Ann Intern Med
Specialty General Medicine
Date 2010 Aug 4
PMID 20679558
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dyslipidemia causes coronary heart disease in middle-aged and elderly adults, but the consequences of lipid exposure during young adulthood are unclear.

Objective: To assess whether nonoptimal lipid levels during young adulthood cause atherosclerotic changes that persist into middle age.

Design: Prospective cohort study.

Setting: 4 cities in the United States.

Participants: 3258 participants from the 5115 black and white men and women recruited at age 18 to 30 years in 1985 to 1986 for the CARDIA (Coronary Artery Risk Development in Young Adults) study.

Measurements: Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides, and coronary calcium. Time-averaged cumulative exposures to lipids between age 20 and 35 years were estimated by using repeated serum lipid measurements over 20 years in the CARDIA study; these measurements were then related to coronary calcium scores assessed later in life (45 years [SD, 4]).

Results: 2824 participants (87%) had nonoptimal levels of LDL cholesterol (>or=2.59 mmol/L [>or=100 mg/dL]), HDL cholesterol (<1.55 mmol/L [<60 mg/dL]), or triglycerides (>or=1.70 mmol/L [>or=150 mg/dL]) during young adulthood. Coronary calcium prevalence 2 decades later was 8% in participants who maintained optimal LDL levels (<1.81 mmol/L [<70 mg/dL]), and 44% in participants with LDL cholesterol levels of 4.14 mmol/L (160 mg/dL) or greater (P < 0.001). The association was similar across race and sex and strongly graded, with odds ratios for coronary calcium of 1.5 (95% CI, 0.7 to 3.3) for LDL cholesterol levels of 1.81 to 2.56 mmol/L (70 to 99 mg/dL), 2.4 (CI, 1.1 to 5.3) for levels of 2.59 to 3.34 mmol/L (100 to 129 mg/dL), 3.3 (CI, 1.3 to 7.8) for levels of 3.37 to 4.12 mmol/L (130 to 159 mg/dL), and 5.6 (CI, 2.0 to 16) for levels of 4.14 mmol/L (160 mg/dL) or greater, compared with levels less than 1.81 mmol/L (<70 mg/dL), after adjustment for lipid exposure after age 35 years and other coronary risk factors. Both LDL and HDL cholesterol levels were independently associated with coronary calcium after participants who were receiving lipid-lowering medications or had clinically abnormal lipid levels were excluded.

Limitation: Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome.

Conclusion: Nonoptimal levels of LDL and HDL cholesterol during young adulthood are independently associated with coronary atherosclerosis 2 decades later.

Primary Funding Source: National Heart, Lung, and Blood Institute.

Citing Articles

Disparities in patterns and outcomes of dyslipidemic patients with acute coronary syndrome: A tertiary cardiac center registry.

Taha H, Alshehri M, El-Hosary H, Elagha A, Mahrous H, Shaker M Atheroscler Plus. 2025; 59():18-24.

PMID: 39802652 PMC: 11722609. DOI: 10.1016/j.athplu.2024.11.004.


Male Gender Expressivity and Diagnosis and Treatment of Cardiovascular Disease Risks in Men.

Glasser N, Jameson J, Huang E, Kronish I, Lindau S, Peek M JAMA Netw Open. 2024; 7(10):e2441281.

PMID: 39453653 PMC: 11512345. DOI: 10.1001/jamanetworkopen.2024.41281.


A twin-driven analysis on early aging biomarkers and associations with sitting-time and physical activity.

Bruellman R, Pahlen S, Ellingson J, Corley R, Wadsworth S, Reynolds C PLoS One. 2024; 19(9):e0308660.

PMID: 39259714 PMC: 11389938. DOI: 10.1371/journal.pone.0308660.


The LDL cumulative exposure hypothesis: evidence and practical applications.

Ference B, Braunwald E, Catapano A Nat Rev Cardiol. 2024; 21(10):701-716.

PMID: 38969749 DOI: 10.1038/s41569-024-01039-5.


Measurement of cumulative high-sensitivity C-reactive protein and monocyte to high-density lipoprotein ratio in the risk prediction of type 2 diabetes: a prospective cohort study.

Wu D, Chen G, Lan Y, Chen S, Ding X, Wei C J Transl Med. 2024; 22(1):110.

PMID: 38281997 PMC: 10822164. DOI: 10.1186/s12967-024-04895-4.


References
1.
Greenland P, Bonow R, Brundage B, Budoff M, Eisenberg M, Grundy S . ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology.... Circulation. 2007; 115(3):402-26. DOI: 10.1161/CIRCULATIONAHA..107.181425. View

2.
Klag M, Ford D, Mead L, He J, Whelton P, Liang K . Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993; 328(5):313-8. DOI: 10.1056/NEJM199302043280504. View

3.
Rubins H, Robins S, Collins D, Fye C, Anderson J, Elam M . Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999; 341(6):410-8. DOI: 10.1056/NEJM199908053410604. View

4.
Agatston A, Janowitz W, HILDNER F, Zusmer N, VIAMONTE Jr M, Detrano R . Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15(4):827-32. DOI: 10.1016/0735-1097(90)90282-t. View

5.
Loria C, Liu K, Lewis C, Hulley S, Sidney S, Schreiner P . Early adult risk factor levels and subsequent coronary artery calcification: the CARDIA Study. J Am Coll Cardiol. 2007; 49(20):2013-20. DOI: 10.1016/j.jacc.2007.03.009. View